SUNNY BUSH: Open Payments
NPI 1548723422 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$811 in 35 payments from 9 companies in 2025. Trend: 2023 $740 · 2024 $641 · 2025 $811
Food & beverage: $711Education: $100
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $194 |
| ABBVIE INC. | 11 | $190 |
| Otsuka America Pharmaceutical, Inc. | 5 | $129 |
| Lundbeck LLC | 4 | $94 |
| Alkermes, Inc. | 2 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| Indivior Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| Almatica Pharma LLC | 1 | $16 |
Products named: VRAYLAR, REXULTI, UZEDY, ARISTADA, ABILIFY ASIMTUFII, CAPLYTA, SUBLOCADE, Auvelity.
Industry payments across CA — which companies pay providers there.
